Cargando…

Association of p53 with Neurodegeneration in Parkinson's Disease

p53 is a vital transcriptional protein implicated in regulating diverse cellular processes, including cell cycle arrest, DNA repair, mitochondrial metabolism, redox homeostasis, autophagy, senescence, and apoptosis. Recent studies have revealed that p53 levels and activity are substantially increase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Qiang, Sun, Wei, Wang, Yi-Fan, Li, Ji, Li, Da-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117072/ https://www.ncbi.nlm.nih.gov/pubmed/35601652 http://dx.doi.org/10.1155/2022/6600944

Ejemplares similares

Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease
por: Gelders, Géraldine, et al.
Publicado: (2018)

Astrocytic expression of Parkinson's disease-related A53T α-synuclein causes neurodegeneration in mice
por: Gu, Xing-Long, et al.
Publicado: (2010)

Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease
por: Marogianni, Chrysoula, et al.
Publicado: (2020)

Potential roles of oxidative distress on neurodegeneration in Parkinson's disease with neuropsychiatric symptoms
por: Li, Dan-ning, et al.
Publicado: (2022)

Shared Mechanisms of Neurodegeneration in Alzheimer's Disease and Parkinson's Disease
por: Xie, Anmu, et al.
Publicado: (2014)

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities
por: Araújo, Bruna, et al.
Publicado: (2022)

Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s Disease
por: Surguchov, Andrei
Publicado: (2021)

Neurodegeneration and neuroprotection in Parkinson's disease /
Publicado: (1996)

Angiogenin and tRNA fragments in Parkinson’s disease and neurodegeneration
por: Prehn, Jochen H M, et al.
Publicado: (2020)

Oxidative Stress Mechanisms Underlying Parkinson’s Disease-Associated Neurodegeneration in C. elegans
por: Chakraborty, Sudipta, et al.
Publicado: (2013)

The Role of LRRK2 in Neurodegeneration of Parkinson Disease
por: Rui, Qin, et al.
Publicado: (2018)

Cyclooxygenase and Neuroinflammation in Parkinson’s Disease Neurodegeneration
por: Bartels, Anna L, et al.
Publicado: (2010)

Unraveling Parkinson’s Disease Neurodegeneration: Does Aging Hold the Clues?
por: Coleman, Colin, et al.
Publicado: (2022)

Single-neuron neurodegeneration as a degenerative model for Parkinson’s disease
por: Huenchuguala, Sandro, et al.
Publicado: (2023)

The Crucial Roles of Pitx3 in Midbrain Dopaminergic Neuron Development and Parkinson’s Disease-Associated Neurodegeneration
por: Wang, Xin, et al.
Publicado: (2023)

Inflammatory Mechanisms of Neurodegeneration in Toxin-Based Models of Parkinson's Disease
por: Litteljohn, Darcy, et al.
Publicado: (2010)

Two distinct trajectories of clinical and neurodegeneration events in Parkinson’s disease
por: Zhou, Cheng, et al.
Publicado: (2023)

Parkinson’s disease managing reversible neurodegeneration
por: Hinz, Marty, et al.
Publicado: (2016)

Cerebrospinal Fluid Cytokines and Neurodegeneration‐Associated Proteins in Parkinson's Disease
por: Wijeyekoon, Ruwani S., et al.
Publicado: (2020)

Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease
por: Lawn, Timothy, et al.
Publicado: (2021)

From cradle to grave: neurogenesis, neuroregeneration and neurodegeneration in Alzheimer’s and Parkinson’s diseases
por: Wakhloo, Debia, et al.
Publicado: (2022)

The Biochemical and Cellular Basis for Nutraceutical Strategies to Attenuate Neurodegeneration in Parkinson’s Disease
por: Mazzio, Elizabeth A., et al.
Publicado: (2011)

Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease
por: Hallett, Penelope J., et al.
Publicado: (2019)

p53-mediated neurodegeneration in the absence of the nuclear protein Akirin2
por: Peek, Stacey L., et al.
Publicado: (2022)

Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's disease
por: Yan, Yi‐Qun, et al.
Publicado: (2023)

Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics
por: Gerlach, Manfred, et al.
Publicado: (2011)

Dopaminergic neurodegeneration in the substantia nigra is associated with olfactory dysfunction in mice models of Parkinson’s disease
por: Yuan, Yu, et al.
Publicado: (2023)

Parkinson's Disease and Neurodegeneration: GABA-Collapse Hypothesis
por: Błaszczyk, Janusz W.
Publicado: (2016)

Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
por: Zeng, Xian-Si, et al.
Publicado: (2018)

Parkinson’s disease managing reversible neurodegeneration [Corrigendum]
Publicado: (2016)

Microbial BMAA and the Pathway for Parkinson’s Disease Neurodegeneration
por: Nunes-Costa, Daniela, et al.
Publicado: (2020)

Parkinson’s Disease Managing Reversible Neurodegeneration [Retraction]
Publicado: (2020)

Mechanisms of Neurodegeneration in Various Forms of Parkinsonism—Similarities and Differences
por: Koziorowski, Dariusz, et al.
Publicado: (2021)

Catecholamines and Neurodegeneration in Parkinson’s Disease—From Diagnostic Marker to Aggregations of α-Synuclein
por: Sawada, Hideyuki, et al.
Publicado: (2013)

Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson’s Disease
por: Mori, Akio, et al.
Publicado: (2020)

Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson’s Disease?
por: Krey, Lea, et al.
Publicado: (2021)

The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer’s Disease, Parkinson’s Disease and Multiple Sclerosis
por: Paolini Paoletti, Federico, et al.
Publicado: (2021)

NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson’s Disease
por: Sirabella, Rossana, et al.
Publicado: (2018)

The c-Abl/p73 pathway induces neurodegeneration in a Parkinson's disease model
por: Marín, Tamara, et al.
Publicado: (2022)

Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-α-synuclein Parkinson’s disease mice
por: Badr, Mohammad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_37ibn3hk908dg2pcg1t2mfldrl